Birdwatch Note
2024-10-21 08:01:34 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
レプリコンのベトナムの臨床試験死亡データは、プラセボ群にもワクチンを打つ前の有効性評価期間であるDay1~Day92において、各郡約8000人の参加者、ワクチン群5人死亡(コロナ死1)、プラセボ群16人死亡(コロナ死9)という結果でした(全ての死亡は接種との因果関関係は認められず)。なので実際は、死亡を減らしたというデータを誤解を招く伝え方をしています。 下記のpdf28pが日本語資料 https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf#page=28 下記が論文です。 https://www.nature.com/articles/s41467-024-47905-1/tables/2 この研究では評価項目に死亡はなく、有意差解析はされていませんが、この差が単純なオッズ比の解析ではゆうに有意差に達していることがわかります。 https://www.medcalc.org/calc/odds_ratio.php
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1848251482614964290
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1848273408683028983
- noteId - 1848273408683028983
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1729497694546
- tweetId - 1848251482614964290
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- レプリコンのベトナムの臨床試験死亡データは、プラセボ群にもワクチンを打つ前の有効性評価期間であるDay1~Day92において、各郡約8000人の参加者、ワクチン群5人死亡(コロナ死1)、プラセボ群16人死亡(コロナ死9)という結果でした(全ての死亡は接種との因果関関係は認められず)。なので実際は、死亡を減らしたというデータを誤解を招く伝え方をしています。 下記のpdf28pが日本語資料 https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf#page=28 下記が論文です。 https://www.nature.com/articles/s41467-024-47905-1/tables/2 この研究では評価項目に死亡はなく、有意差解析はされていませんが、この差が単純なオッズ比の解析ではゆうに有意差に達していることがわかります。 https://www.medcalc.org/calc/odds_ratio.php
Note Ratings
rated at | rated by | |
2024-10-24 18:04:45 -0500 | Rating Details | |
2024-10-24 06:12:21 -0500 | Rating Details | |
2024-10-22 07:35:34 -0500 | Rating Details | |
2024-10-21 18:21:24 -0500 | Rating Details | |
2024-10-21 09:10:36 -0500 | Rating Details | |
2024-10-21 08:48:46 -0500 | Rating Details | |
2024-10-21 07:00:23 -0500 | Rating Details | |
2024-10-21 05:45:28 -0500 | Rating Details | |
2024-10-21 05:31:33 -0500 | Rating Details | |
2024-10-21 04:39:57 -0500 | Rating Details | |
2024-10-21 04:08:01 -0500 | Rating Details | |
2024-10-21 04:07:03 -0500 | Rating Details | |
2024-10-21 03:03:23 -0500 | Rating Details | |
2024-10-24 16:25:16 -0500 | Rating Details | |
2024-10-24 01:17:48 -0500 | Rating Details | |
2024-10-22 02:16:50 -0500 | Rating Details | |
2024-10-21 17:08:59 -0500 | Rating Details | |
2024-10-21 07:15:09 -0500 | Rating Details | |
2024-10-21 06:31:21 -0500 | Rating Details | |
2024-10-21 05:38:45 -0500 | Rating Details | |
2024-10-21 05:20:22 -0500 | Rating Details | |
2024-10-21 03:57:43 -0500 | Rating Details | |
2024-10-21 03:46:20 -0500 | Rating Details | |
2024-10-21 03:37:49 -0500 | Rating Details | |
2024-10-21 03:30:57 -0500 | Rating Details | |
2024-10-21 03:18:26 -0500 | Rating Details | |
2024-10-21 03:11:36 -0500 | Rating Details | |
2024-10-24 06:45:34 -0500 | Rating Details | |
2024-10-24 05:35:47 -0500 | Rating Details | |
2024-10-24 03:57:49 -0500 | Rating Details | |
2024-10-24 03:37:55 -0500 | Rating Details | |
2024-10-21 20:27:51 -0500 | Rating Details | |
2024-10-21 09:42:13 -0500 | Rating Details | |
2024-10-21 09:39:14 -0500 | Rating Details | |
2024-10-21 06:08:12 -0500 | Rating Details | |
2024-10-21 04:32:34 -0500 | Rating Details | |
2024-10-21 04:24:14 -0500 | Rating Details | |
2024-10-21 04:19:11 -0500 | Rating Details | |
2024-10-21 03:52:03 -0500 | Rating Details | |
2024-10-21 03:38:12 -0500 | Rating Details | |
2024-10-21 03:29:07 -0500 | Rating Details | |
2024-10-21 03:06:06 -0500 | Rating Details | |
2024-10-26 12:42:30 -0500 | Rating Details | |
2024-10-24 05:58:37 -0500 | Rating Details | |
2024-10-24 04:52:41 -0500 | Rating Details | |
2024-10-24 04:44:28 -0500 | Rating Details | |
2024-10-24 02:07:13 -0500 | Rating Details | |
2024-10-24 01:46:56 -0500 | Rating Details | |
2024-10-21 16:44:56 -0500 | Rating Details | |
2024-10-21 11:47:14 -0500 | Rating Details | |
2024-10-21 10:18:30 -0500 | Rating Details | |
2024-10-21 07:44:10 -0500 | Rating Details | |
2024-10-21 07:04:10 -0500 | Rating Details | |
2024-10-21 04:51:30 -0500 | Rating Details | |
2024-10-21 04:14:31 -0500 | Rating Details | |
2024-10-21 03:20:32 -0500 | Rating Details | |
2024-10-24 09:10:34 -0500 | Rating Details | |
2024-10-24 04:05:44 -0500 | Rating Details | |
2024-10-24 02:58:22 -0500 | Rating Details | |
2024-10-21 18:04:13 -0500 | Rating Details | |
2024-10-21 17:23:47 -0500 | Rating Details | |
2024-10-21 04:48:16 -0500 | Rating Details | |
2024-10-21 04:30:24 -0500 | Rating Details | |
2024-10-21 04:18:03 -0500 | Rating Details | |
2024-10-21 04:07:59 -0500 | Rating Details | |
2024-10-21 03:15:53 -0500 | Rating Details |